PURIBLOOD MEDICAL CO., LTD. Puriblood Medical Co., Ltd. Stock
Equities
6847
TW0006847007
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.5 TWD | -0.91% |
|
-3.12% | -3.56% |
| Sales 2022 | 137M 4.24M 5.78M | Sales 2023 | 125M 3.86M 5.27M | Capitalization | 1.6B 49.35M 67.33M |
|---|---|---|---|---|---|
| Net income 2022 | 16M 493K 673K | Net income 2023 | -51M -1.57M -2.14M | EV / Sales 2022 | 13.7 x |
| Net cash position 2022 | 42.89M 1.32M 1.8M | Net cash position 2023 | 65.84M 2.03M 2.77M | EV / Sales 2023 | 12.3 x |
| P/E ratio 2022 |
117
x | P/E ratio 2023 |
-31
x | Employees | 42 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
| 1 day | -0.91% | ||
| 1 week | -3.12% | ||
| Current month | -1.81% | ||
| 1 month | -0.46% | ||
| 3 months | -6.47% | ||
| 6 months | -3.98% | ||
| Current year | -3.56% |
1 week
105.00
113.00
1 month
105.00122.50
Current year
105.00134.00
1 year
104.50134.00
3 years
100.00190.00
5 years
100.00190.00
10 years
100.00190.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yung Chang
FOU | Founder | - | 15-12-31 |
Luke Chen
PSD | President | - | - |
Ken Zhong
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yanwen Chen
CHM | Chairman | - | - |
Yong Zhang
BRD | Director/Board Member | - | - |
Zheng Feng Zhong
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-25 | 108.5 | -0.91% | 19,117 |
| 24-06-24 | 109.5 | -0.90% | 32,068 |
| 24-06-21 | 110.5 | -1.34% | 1,017 |
| 24-06-20 | 112 | +0.45% | 15,308 |
| 24-06-19 | 111.5 | -0.89% | 5,202 |
End-of-day quote Taipei Exchange, June 24, 2024
More quotes
Puriblood Medical Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and development of anti-pseudo-type leukocyte filters and the manufacture of dual-ion polymer technology related medical equipment. The Company mainly develops blood purification-related medical equipment. The products include anti-blood-type leukocyte reduction filters for blood transfusion, which are used to reduce the number of white blood cells in red blood cell concentrates to reduce transfusion reactions; animal blood filters, which are used to reduce the number of white blood cells in animal blood to reduce transfusion reactions; animal blood bags, which are used to store blood; micro filters, which are used to remove interference from human cell signals or the number of white blood cells.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.56% | 48.12M | |
| +12.99% | 6.83B | |
| -31.51% | 6.76B | |
| +8.94% | 5.2B | |
| -19.51% | 4.69B | |
| +14.44% | 4.1B | |
| -22.71% | 3.81B | |
| -29.50% | 2.67B | |
| +20.83% | 2.01B | |
| -1.86% | 2B |
- Stock Market
- Equities
- 6847 Stock
